Efficacy, tolerability, and safety of erenumab for the preventive treatment of persistent post-traumatic headache attributed to mild traumatic brain injury: an open-label study

BACKGROUND: Calcitonin gene-related peptide (CGRP) has recently been implicated in the pathogenesis of post-traumatic headache (PTH), which raises the prospect for therapeutic use of monoclonal antibodies targeting CGRP or its receptor. Therefore, we decided to assess the efficacy, tolerability, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashina, Håkan, Iljazi, Afrim, Al-Khazali, Haidar Muhsen, Eigenbrodt, Anna Kristina, Larsen, Eigil Lindekilde, Andersen, Amalie Middelboe, Hansen, Kevin John, Bräuner, Karoline Bendix, Mørch-Jessen, Thomas, Chaudhry, Basit, Antic, Sonja, Christensen, Casper Emil, Ashina, Messoud, Amin, Faisal Mohammad, Schytz, Henrik Winther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271543/
https://www.ncbi.nlm.nih.gov/pubmed/32493206
http://dx.doi.org/10.1186/s10194-020-01136-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271543/
https://www.ncbi.nlm.nih.gov/pubmed/32493206
http://dx.doi.org/10.1186/s10194-020-01136-z

Ejemplares similares